« Return to News | Awards & Advancement

Texas Health Resources selects Daniel Varga as CCO

Wednesday, December 19, 2012 12:08 PM

Texas Health Resources, a faith-based, nonprofit health system, has selected Daniel Varga, M.D., as its chief clinical officer (CCO) and senior executive vice president of the health system, effective Jan. 14.

Varga will be responsible for achieving full and seamless integration of the entire Texas Health clinical enterprise, including quality, patient safety and patient experience initiatives. He will also oversee physician relationships, clinical integration, care design and clinical research and education. Varga will work hand-in-hand with Barclay Berdan, the system's COO and senior executive vice president, and they will have joint responsibility for execution of the next phase of Texas Health's 10-year strategic plan launched in 2007.

Varga comes to Texas Health with 24 years of combined experience in patient practice, medical education and health care administration. He served in a number of senior clinical leadership roles in large health care organizations, most recently as the CCO at KentuckyOne Health, the largest health system in Kentucky. Prior to this position, he served as chief medical officer (CMO) at Saint Joseph Health System in Lexington, Ky.; regional vice president-CMO at SSM Healthcare-Saint Louis; senior vice president and CMO at Norton Healthcare in Louisville, Ky.; and founder and president of Community Medical Associates, a large primary care physician group.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.